• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铱(III)配合物通过PI3K/AKT/mTOR信号通路抑制BEL-7402细胞的增殖和迁移。

Iridium(III) complexes inhibit the proliferation and migration of BEL-7402 cells through the PI3K/AKT/mTOR signaling pathway.

作者信息

Chen Jing, Liu Haimei, Chen Yichuan, Hu Huiyan, Huang Chunxia, Wang Yi, Liang Lijuan, Liu Yunjun

机构信息

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China; Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Guangdong Pharmaceutical University, Guangzhou, 510006, PR China.

出版信息

J Inorg Biochem. 2023 Apr;241:112145. doi: 10.1016/j.jinorgbio.2023.112145. Epub 2023 Jan 23.

DOI:10.1016/j.jinorgbio.2023.112145
PMID:36709684
Abstract

Iridium(III) complexes are largely studied as anti-cancer complexes due to their excellent anti-cancer activity. In this article, two new iridium(III) complexes [Ir(piq)(THPIP)]PF (THPIP = 2,4-di-tert-butyl-6-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol, piq = deprotonated 1-phenylisoquinoline) (Ir1) and [Ir(bzq)(THPIP)]PF (bzq = deprotonated benzo[h]quinolone) (Ir2) were synthesized. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays showed that complex Ir1 exhibits moderate activity (IC = 29.9 ± 4.6 μM) and Ir2 shows high cytotoxicity (IC = 9.8 ± 1.8 μM) against BEL-7402 cells. Further studies on the mechanism showed that Ir1 and Ir2 induced apoptosis by changing the mitochondrial membrane potential, Ca release, ROS accumulation, and cell cycle arrest at the S phase. The complexes can effectively inhibit cell colony formation and migration. The expression of B-cell lymphoma-2 (Bcl-2) family proteins, PI3K (phosphatidylinositol 3-kinase), AKT (protein kinase B), mTOR (mammalian target of rapamycin), and p-mTOR was studied by immunoblotting. Complexes Ir1 and Ir2 downregulated the expression of anti-apoptotic protein Bcl-2 and increased the expression of autophagy-related proteins of Beclin-1 and LC3-II. Further experiments showed that the complexes inhibited the production of glutathione (GSH) and increased the amounts of malondialdehyde (MDA). Fluorescence of HMGB1 was significantly increased. We also investigated the effect of the complexes on the expression of genes using RNA-sequence analysis, we further calculated the lowest binding energies between the complexes and proteins using molecular docking. Taken together, the above results indicated that complexes Ir1 and Ir2 induce apoptosis in BEL-7402 cells through a ROS-mediated mitochondrial dysfunction and inhibition of the PI3K/AKT/mTOR signaling pathway.

摘要

铱(III)配合物因其出色的抗癌活性而被广泛研究作为抗癌配合物。在本文中,合成了两种新型铱(III)配合物[Ir(piq)(THPIP)]PF(THPIP = 2,4 - 二叔丁基 - 6 -(1H - 咪唑并[4,5 - f][1,10]菲咯啉 - 2 - 基)苯酚,piq = 去质子化的1 - 苯基异喹啉)(Ir1)和[Ir(bzq)(THPIP)]PF(bzq = 去质子化的苯并[h]喹诺酮)(Ir2)。3 -(4,5 - 二甲基噻唑 - 2 - 基)- 2,5 - 二苯基四氮唑溴盐(MTT)实验表明,配合物Ir1对BEL - 7402细胞表现出中等活性(IC = 29.9 ± 4.6 μM),而Ir2显示出高细胞毒性(IC = 9.8 ± 1.8 μM)。对作用机制的进一步研究表明,Ir1和Ir2通过改变线粒体膜电位、钙释放、活性氧积累以及使细胞周期停滞在S期来诱导细胞凋亡。这些配合物能有效抑制细胞集落形成和迁移。通过免疫印迹研究了B细胞淋巴瘤 - 2(Bcl - 2)家族蛋白、磷脂酰肌醇3 - 激酶(PI3K)、蛋白激酶B(AKT)、雷帕霉素靶蛋白(mTOR)和磷酸化mTOR的表达。配合物Ir1和Ir2下调抗凋亡蛋白Bcl - 2的表达,并增加自噬相关蛋白Beclin - 1和LC3 - II的表达。进一步实验表明,这些配合物抑制谷胱甘肽(GSH)的产生并增加丙二醛(MDA)的量。高迁移率族蛋白B1(HMGB1)的荧光显著增加。我们还使用RNA序列分析研究了配合物对基因表达的影响,通过分子对接进一步计算了配合物与蛋白质之间的最低结合能。综上所述,上述结果表明配合物Ir1和Ir2通过活性氧介导的线粒体功能障碍和抑制PI3K/AKT/mTOR信号通路诱导BEL - 7402细胞凋亡。

相似文献

1
Iridium(III) complexes inhibit the proliferation and migration of BEL-7402 cells through the PI3K/AKT/mTOR signaling pathway.铱(III)配合物通过PI3K/AKT/mTOR信号通路抑制BEL-7402细胞的增殖和迁移。
J Inorg Biochem. 2023 Apr;241:112145. doi: 10.1016/j.jinorgbio.2023.112145. Epub 2023 Jan 23.
2
Iridium(III)-BBIP complexes induce apoptosis via PI3K/AKT/mTOR pathway and inhibit A549 lung tumor growth in vivo.铱(III)-BBIP 配合物通过 PI3K/AKT/mTOR 通路诱导细胞凋亡,并抑制体内 A549 肺肿瘤生长。
J Inorg Biochem. 2021 Oct;223:111550. doi: 10.1016/j.jinorgbio.2021.111550. Epub 2021 Jul 21.
3
Design, synthesis and biological evaluation of liposome entrapped iridium(III) complexes toward SGC-7901 cells.脂质体包裹的铱(III)配合物对SGC - 7901细胞的设计、合成及生物学评价
J Inorg Biochem. 2023 Apr;241:112134. doi: 10.1016/j.jinorgbio.2023.112134. Epub 2023 Jan 21.
4
Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway.铱(III)配合物通过扰乱细胞氧化还原稳态失衡和抑制 PI3K/AKT/mTOR 通路诱导宫颈癌细胞凋亡。
J Inorg Biochem. 2022 Oct;235:111946. doi: 10.1016/j.jinorgbio.2022.111946. Epub 2022 Jul 29.
5
Light activation of iridium(III) complexes driving ROS production and DNA damage enhances anticancer activity in A549 cells.光激活铱(III)配合物促进活性氧产生和 DNA 损伤,增强 A549 细胞中的抗癌活性。
J Inorg Biochem. 2022 Nov;236:111977. doi: 10.1016/j.jinorgbio.2022.111977. Epub 2022 Aug 23.
6
DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.DNA 结合及铱(III)多吡啶配合物的体外和体内抗癌活性评价。
J Inorg Biochem. 2021 Nov;224:111580. doi: 10.1016/j.jinorgbio.2021.111580. Epub 2021 Aug 16.
7
Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.针对 DNA 和线粒体的铱(III)多吡啶配合物的体外和体内抗癌效果评价。
Bioorg Chem. 2021 Oct;115:105290. doi: 10.1016/j.bioorg.2021.105290. Epub 2021 Aug 19.
8
Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells.三价铱(III)多吡啶配合物的合成、表征及对结肠癌 HCT116 细胞的抗癌活性研究。
Molecules. 2022 Aug 25;27(17):5434. doi: 10.3390/molecules27175434.
9
Synthesis, biological evaluation of novel iridium(III) complexes targeting mitochondria toward melanoma B16 cells.新型靶向黑色素瘤 B16 细胞线粒体的铱(III)配合物的合成及生物学评价。
Eur J Med Chem. 2023 Feb 5;247:115046. doi: 10.1016/j.ejmech.2022.115046. Epub 2022 Dec 22.
10
Anticancer mechanism studies of iridium(III) complexes inhibiting osteosarcoma HOS cells proliferation.三价铱配合物抑制骨肉瘤 HOS 细胞增殖的抗癌机制研究。
J Inorg Biochem. 2022 Dec;237:112011. doi: 10.1016/j.jinorgbio.2022.112011. Epub 2022 Sep 20.

引用本文的文献

1
Cyclometalated complexes: promising metallodrugs in the battle against cancer.环金属化配合物:抗癌斗争中颇具潜力的金属药物。
RSC Med Chem. 2025 Jul 31. doi: 10.1039/d5md00178a.
2
Radiosensitization effect of iridium (III) complex on lung cancer cells via mitochondria apoptosis pathway.铱(III)配合物通过线粒体凋亡途径对肺癌细胞的放射增敏作用
Front Pharmacol. 2025 Mar 27;16:1562228. doi: 10.3389/fphar.2025.1562228. eCollection 2025.